巨子 ICON - 財經股票資訊及專家分析
快訊
資訊
    虛擬市場
    搜尋 股票/指數/編號

    快訊

    資訊

    Impel Pharmaceuticals

    IMPL
    8.720
    0.010
    0.11%
    最少15分鐘延遲,股票資訊由第三方資訊供應商提供
    ・Impel Pharmaceuticals - 延遲價格・最後更新於 12/08 12:00
    最高位
    8.880
    最低位
    8.600
    開市價
    --
    前收市價
    8.710
    成交量(千)
    0.73
    成交額(百萬)
    0.06
    買入
    --
    賣出
    --
    每手股數
    --
    市值(百萬)
    202.09
    市盈率
    --
    息率
    --
    差價
    --
    52週高低
    34.750 - 5.720
    所有資料不保證絕對正確、完整、或實時,僅作為參考使用。投資涉及風險,過往業績並不代表將來表現,作任何投資決定或交易前,閣下應諮詢獨立專業意見。所有內容均不構成投資建議。

    企業資料

    公司名稱
    Impel Pharmaceuticals
    證券代碼
    IMPL.US
    所屬板塊
    Biotechnology
    公司業務
    Impel Pharmaceuticals Inc is a commercial-stage pharmaceutical company focused on utilizing its proprietary technology to develop and commercialize transformative therapies for patients suffering from diseases with high unmet medical needs, with an initial focus on diseases of the central nervous system. The company is developing an approach to drug delivery that administers specific formulations of drugs deep into the vascular-rich upper nasal space, a gateway for therapeutic administration of a versatile range of molecules and formulations.
    發行量
    23175242
    公司總部
    201 Elliott Avenue West, Suite 260
    公司網址
    https://www.impelpharma.com
    公司電話
    +1 206 568-1466
    暫無內容

    關於

    Impel Pharmaceuticals(IMPL.US)所屬的行業板塊為Biotechnology。
    Impel Pharmaceuticals Inc is a commercial-stage pharmaceutical company focused on utilizing its proprietary technology to develop and commercialize transformative therapies for patients suffering from diseases with high unmet medical needs, with an initial focus on diseases of the central nervous system. The company is developing an approach to drug delivery that administers specific formulations of drugs deep into the vascular-rich upper nasal space, a gateway for therapeutic administration of a versatile range of molecules and formulations.
    詳細公司背景可參考: https://www.impelpharma.com